MAPT and Alzheimer disease: Although we corroborate previous findings [21, 23, 29, 42] on decreased expression of MAPT-AS1 and MAPT in the entorhinal cortex of AD cases compared to controls, it is most likely that this observation is predominantly driven by the neuronal loss that occurs in AD patients at advanced Braak stages [43].